Daito Pharmaceutical Co., Ltd. ( (JP:4577) ) just unveiled an update.
Daito Pharmaceutical Co., Ltd. has announced the repurchase of 83,600 of its own shares, amounting to 171,019,300 yen, as part of a strategic move to enhance shareholder value. This repurchase is part of a broader plan approved by the Board of Directors to buy back up to 300,000 shares, reflecting the company’s commitment to optimizing its capital structure and potentially increasing its stock market performance.
More about Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is listed on the Prime Market of the Tokyo Stock Exchange.
YTD Price Performance: -3.11%
Average Trading Volume: 32,067
Technical Sentiment Consensus Rating: Buy
Current Market Cap: Yen31.07B
See more data about 4577 stock on TipRanks’ Stock Analysis page.